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Introduction
Neuromodulatory devices offer additional treatment
options to refractory pharmacologic intervention for the
treatment of chronic cluster headaches (CH). Clinical
experience suggests vagus nerve stimulation (VNS) may
be beneficial; however, inherent risks are associated with
surgical implantation. As such, a need for the development
of a non-invasive VNS (nVNS) modality exists.
Aim
Evaluate the long-term effects of an nVNS device (gamma-
Core®) in the extension phase of the Prevention and Acute
(PREVA) Treatment of Chronic Cluster Headache study.
Methods
This randomized, controlled study consisted of a 2-week
run-in phase, followed by a 4-week randomized (1:1;
nVNS vs standard of care [SoC]) phase, and a 4-week
extension phase. During the extension phase, subjects
delivered 3 consecutive 90-second stimulations prophylac-
tically twice daily (mandatory, right side only) and
optionally at the onset of a CH attack (2 stimulations on
headache side, 1 on opposite side) for rescue treatment.
Efficacy end points evaluated in the extension phase were
mean number of all CH attacks, pain intensity (range: no
pain to very severe pain), treatment success rate, and use
of rescue medication. Safety was assessed by monitoring
the frequency of adverse events.
Results
A total of 97 subjects, across 10 European sites, were ran-
domized to treatment; 90 entered the extension phase. All
data has been collected and will be available for presenta-
tion at EHMTIC.
Conclusion
Findings from PREVA are expected to provide further
evidence of the sustained clinical effects and continued
safety of nVNS in the treatment of chronic CH.
Abstract submitted on behalf of the PREVA Study
Investigators.
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